---
title: "CHD2"
date: 2023-05-11 00:00:00
layout: post
categories: Gene
summary: "## Analysis of Gene CHD2"
tags: ['CHD2', 'GeneticInformation', 'MissenseMutation', 'EpilepticEncephalopathy', 'AutismSpectrumDisorder', 'Treatment', 'Prognosis', 'ResearchPaper']
---

## Analysis of Gene CHD2

### Gene Information 

- Gene Name: CHD2
- Function: Chromodomain Helicase DNA Binding Protein 2; Transcriptional regulator
- Genomic Location: Chr15, 51.65 - 51.71 Mb
- Aliases: KIAA1241, DKFZP586C0522

### External IDs

- HGNC ID: 1988
- NCBI Entrez Gene ID: 1109
- Ensembl Gene ID: ENSG00000137845
- OMIM ID: 602119
- UniProtKB/Swiss-Prot ID: O14647

### Mutations

- AA Mutation List:
    - c.560C>T (p.Arg187Cys)
    - c.3913G>A (p.Asp1305Asn)
    - c.4313C>T (p.Ala1438Val)
- Mutation Type: Missense
- dbSNP IDs: rs375841487, rs778105371, rs886041700

### Somatic SNVs/InDels

- dbSNP IDs: rs1418655963, rs277732180, rs1135464699

### Related Diseases

- Epileptic encephalopathy, early infantile, 16 (OMIM: 615338)
- Autism spectrum disorder (OMIM: 209850)

### Treatment and Prognosis

- Treatment is targeted to symptom management and behavior modification. 
- Prognosis depends on the severity of the disease and its associated symptoms.

### Drug Response

- There are no current drug therapies to treat CHD2-related diseases.

### Related Papers

- Subject: CHD2
- Author: Zhang Y et al.
- Paper: ["Mutation analysis of CHD2 gene in Chinese patients with early-onset epileptic encephalopathy"]([Click](https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.61799)
- DOI: 10.1002/ajmg.a.61799

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**